相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Elevated Soluble Fms-Like Tyrosine Kinase-1 and Placental-Like Growth Factor Levels Are Associated With Development and Mortality Risk in Heart Failure
Muhammad Hammadah et al.
CIRCULATION-HEART FAILURE (2016)
Lipids, Statins and Heart Failure: An Update
Niki Katsiki et al.
CURRENT PHARMACEUTICAL DESIGN (2016)
Cardiomyocyte mitochondrial oxidative stress and cytoskeletal breakdown in the heart with a primary volume overload
Danielle M. Yancey et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2015)
Paraoxonase-1 and oxidized lipoprotein lipids. The Cardiovascular Risk in Young Finns Study
Petri Kresanov et al.
ATHEROSCLEROSIS (2015)
Reactive oxidative metabolites are associated with the severity of heart failure and predict future cardiovascular events in heart failure with preserved left ventricular ejection fraction
Yoshihiro Hirata et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2015)
The effects of atorvastatin on antioxidant/antiinflammatory properties of HDLs in hypercholesterolemics
Gulsen Akalin Ciftci et al.
TURKISH JOURNAL OF MEDICAL SCIENCES (2015)
Prognostic Value of Elevated Serum Ceruloplasmin Levels in Patients With Heart Failure
Muhammad Hammadah et al.
JOURNAL OF CARDIAC FAILURE (2014)
Myeloperoxidase, paraoxonase-1, and HDL form a functional ternary complex
Ying Huang et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
A Novel Paradigm for Heart Failure With Preserved Ejection Fraction Comorbidities Drive Myocardial Dysfunction and Remodeling Through Coronary Microvascular Endothelial Inflammation
Walter J. Paulus et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Clinical and Genetic Association of Serum Paraoxonase and Arylesterase Activities With Cardiovascular Risk
W. H. Wilson Tang et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2012)
Eplerenone in Patients With Systolic Heart Failure and Mild Symptoms Analysis of Repeat Hospitalizations
Jennifer K. Rogers et al.
CIRCULATION (2012)
Paraoxonase-1 is not associated with coronary artery calcification in type 2 diabetes: Results from the PREDICT study
Bharti Mackness et al.
DISEASE MARKERS (2012)
Diminished Antioxidant Activity of High-Density Lipoprotein-Associated Proteins in Systolic Heart Failure
W. H. Wilson Tang et al.
CIRCULATION-HEART FAILURE (2011)
Paraoxonase 1 protects against protein N-homocysteinylation in humans
Joanna Perla-Kajan et al.
FASEB JOURNAL (2010)
Autophagy, Redox Signaling, and Ventricular Remodeling
Narasimman Gurusamy et al.
ANTIOXIDANTS & REDOX SIGNALING (2009)
Relations of Lipid Concentrations to Heart Failure Incidence The Framingham Heart Study
Raghava S. Velagaleti et al.
CIRCULATION (2009)
Racial Differences in Incident Heart Failure among Young Adults
Kirsten Bibbins-Domingo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Both Paraoxonase-1 Genotype and Activity Do Not Predict the Risk of Future Coronary Artery Disease; the EPIC-Norfolk Prospective Population Study
Rakesh S. Birjmohun et al.
PLOS ONE (2009)
The role of leukocyte-generated oxidants in left ventricular remodeling
Marc S. Penn
AMERICAN JOURNAL OF CARDIOLOGY (2008)
The human paraoxonase-1 phenotype modifies the effect of statins on paraoxonase activity and lipid parameters
Hossein Z. Mirdamadi et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2008)
Factors associated with paraoxonase genotypes and activity in a diverse, young, healthy population: The coronary artery risk development in young adults (CARDIA) study
Bharat Thyagarajan et al.
CLINICAL CHEMISTRY (2008)
Comparison of the Andersen-Gill model with poisson and negative binomial regression on recurrent event data
Antje Jahn-Eirriermacher
COMPUTATIONAL STATISTICS & DATA ANALYSIS (2008)
Association of paraoxonase activity and coronary collateral flow
Ali Yildiz et al.
CORONARY ARTERY DISEASE (2008)
Differential effects of arginine methylation on diastolic dysfunction and disease progression in patients with chronic systolic heart failure
Wai Hong Wilson Tang et al.
EUROPEAN HEART JOURNAL (2008)
Relationship of paraoxonase 1 (PON1) gene polymorphisms and functional activity with systemic oxidative stress and cardiovascular risk
Tamali Bhattacharyya et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial
Luigi Tavazzi et al.
LANCET (2008)
Rosuvastatin in older patients with systolic heart failure
John Kjekshus et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Coronary artery disease risk factors in patients with schizophrenia: effects of short term antipsychotic treatment
Asli Sarandol et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2007)
Atherosclerosis and oxidant stress: The end of the road for antioxidant vitamin treatment?
Mika J. Thomson et al.
CARDIOVASCULAR DRUGS AND THERAPY (2007)
Plasma myeloperoxidase levels in patients with chronic heart failure
W. H. Wilson Tang et al.
AMERICAN JOURNAL OF CARDIOLOGY (2006)
Association of paraoxonase-1 activity and concentration with angiographic severity and extent of coronary artery disease
M Granér et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Paraoxonase-1 activity modulates endothelial function in patients with peripheral arterial disease
L Pasqualini et al.
ATHEROSCLEROSIS (2005)
Association of genes of lipid metabolism with measures of subclinical cardiovascular disease in the Diabetes Heart Study
KP Burdon et al.
JOURNAL OF MEDICAL GENETICS (2005)
Low paraoxonase activity predicts coronary events in the caerphilly prospective study
B Mackness et al.
CIRCULATION (2003)
Myeloperoxidase and plasminogen activator inhibitor 1 play a central role in ventricular remodeling after myocardial infarction
AT Askari et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Paraoxonase status in coronary heart disease - Are activity and concentration more important than genotype?
B Mackness et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2001)
Effect of simvastatin therapy on paraoxonase activity and related lipoproteins in familial hypercholesterolemic patients
M Tomas et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2000)
分享论文
